Department of Nuclear Medicine, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
Division of Medical Humanities & Behavioral sciences, Tongji University School of Medicine, Shanghai, China.
Support Care Cancer. 2018 Sep;26(9):3267-3275. doi: 10.1007/s00520-018-4172-7. Epub 2018 Apr 11.
Thyroid cancer, especially differentiated thyroid cancer (DTC), is a highly prevalent chronic disease that is known to cause considerable distress, related both to the high recurrence and treatment of the disease. The Pictorial Representation of Illness and Self Measure-Revised 2 (PRISM-R2) has been developed as a visual measure to assess suffering. The aim of this study was to evaluate the ability of the instrument to identify patients with DTC with different levels of suffering who may need additional support care.
Participants were 338 adult inpatients with DTC who were accepting the radioiodine for remnant ablation in the nuclear medicine department. The assessment tools included the following: (1) the PRISM-R2, yielding Self-Illness Separation (SIS) and Illness Perception Measure (IPM); (2) distress thermometer (DT), a measure of thyroid cancer-related distress; (3) posttraumatic growth inventory (PTGI); (4) 12-item Short-Form health survey (SF-12); and (5) the Supportive Care Needs Survey Short Form (SCNS-SF34). In addition, the content validity of PRISM-R2 was tested using the patients' comments.
SIS and IPM showed medium intercorrelation (r = -.482; p < 0.01), and both of them showed strongly significant associations with DT. SIS also showed significant correlations with one factor of PTGI (personal strength), four factors of SF-12 (general health, role-emotional, mental health, and vitality), and one factor of SCNS-SF34 (psychological needs). IPM showed significant correlations with five factors of SF-12 and all the factors of SCNS-SF34. No correlation was found between IPM and PTGI.
PRISM-R2 is a well-accepted and understandable tool to assess the psychological burden of patients with thyroid cancer in Chinese settings. It may be useful to guide or evaluate the interventions for the patients.
甲状腺癌,特别是分化型甲状腺癌(DTC),是一种高发的慢性疾病,已知会导致相当大的痛苦,既与疾病的高复发率和治疗有关。疾病形象描绘量表修订版 2(PRISM-R2)是一种视觉测量工具,用于评估痛苦。本研究的目的是评估该工具识别 DTC 患者不同痛苦水平的能力,这些患者可能需要额外的支持性护理。
参与者为 338 名在核医学科接受放射性碘残留消融治疗的 DTC 成年住院患者。评估工具包括:(1)PRISM-R2,产生自我疾病分离(SIS)和疾病感知测量(IPM);(2)疾病相关痛苦温度计(DT);(3)创伤后成长量表(PTGI);(4)12 项简明健康调查量表(SF-12);(5)支持性护理需求调查简表(SCNS-SF34)。此外,还使用患者的意见测试了 PRISM-R2 的内容效度。
SIS 和 IPM 显示中等的相关性(r=-.482;p<0.01),且两者均与 DT 有强烈的显著关联。SIS 还与 PTGI 的一个因子(个人力量)、SF-12 的四个因子(一般健康、角色情感、心理健康和活力)和 SCNS-SF34 的一个因子(心理需求)有显著的相关性。IPM 与 SF-12 的五个因子和 SCNS-SF34 的所有因子均有显著相关性。IPM 与 PTGI 无相关性。
PRISM-R2 是一种在中国人群中评估甲状腺癌患者心理负担的可接受和易于理解的工具。它可能有助于指导或评估患者的干预措施。